ANTIPODES PARTNERS Ltd

Position in QGEN — Qiagen N.V.

CIK 1652442 ROYAL EXCHANGE, C3

Position in QGEN

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$79,639

+$6,024 QoQ

Shares Held

1,989

+21.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ANTIPODES PARTNERS Ltd holds $32,110,014 across 4 Diagnostics & Research names. QGEN ranks #3 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DGX	Quest Diagnostics Inc	162,589	$31,864,192
2	WAT	Waters Corp /De/	370	$110,186
3	QGEN	Qiagen N.V. This page	1,989	$79,639
4	NTRA	Natera, Inc.	280	$55,997

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$79,639	1,989	+21.5%	Shares	Sole	2026-05-05
2025-12-31	$73,615	1,637	—	Shares	Sole	2026-02-05
No filing history on record for this holder in this stock.